Home
/
Senti Biosciences, Inc.
/
Financials
/
Quarterly
Senti Biosciences, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Senti Biosciences, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$0
Nov 14, 2024
Q2
2024
Jun 30, 2024
$0
Aug 13, 2024
Q1
2024
Mar 31, 2024
$0
May 9, 2024
Q3
2024
Sep 30, 2023
$338.0K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$937.0K
Aug 13, 2024
Q1
2024
Mar 31, 2023
$1.29M
May 9, 2024
Q3
2023
Sep 30, 2022
$1.77M
Nov 14, 2023
Q2
2023
Jun 30, 2022
$1.36M
Aug 11, 2023
Q1
2023
Mar 31, 2022
$1.10M
May 9, 2023
Q3
2022
Sep 30, 2021
$1.10M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$793.0K
Aug 15, 2022
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$0
Nov 14, 2024
Q2
2024
Jun 30, 2024
$0
Aug 13, 2024
Q1
2024
Mar 31, 2024
$0
May 9, 2024
Q3
2024
Sep 30, 2023
$255.0K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$687.0K
Aug 13, 2024
Q1
2024
Mar 31, 2023
$1.04M
May 9, 2024
Q3
2023
Sep 30, 2022
$1.52M
Nov 14, 2023
Q2
2023
Jun 30, 2022
$1.11M
Aug 11, 2023
Q1
2023
Mar 31, 2022
$854.0K
May 9, 2023
Q3
2022
Sep 30, 2021
$926.0K
Nov 10, 2022
Q2
2022
Jun 30, 2021
$778.0K
Aug 15, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($18.13M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($14.73M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($14.73M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($14.11M)
May 6, 2025
Q3
2025
Mar 31, 2025
($14.11M)
Nov 13, 2025
Q2
2025
Mar 31, 2025
($14.11M)
Aug 7, 2025
Q3
2025
Sep 30, 2024
($28.87M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($11.20M)
Aug 7, 2025
Q3
2025
Jun 30, 2024
($11.20M)
Nov 13, 2025
Q1
2025
Mar 31, 2024
($12.11M)
May 6, 2025
Q2
2025
Mar 31, 2024
($12.11M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($12.11M)
Nov 13, 2025
Q3
2024
Sep 30, 2023
($14.92M)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($18.70M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($18.70M)
Aug 13, 2024
Q2
2024
Mar 31, 2023
($18.72M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($18.72M)
May 9, 2024
Q3
2024
Mar 31, 2023
($18.72M)
Nov 14, 2024
Q3
2023
Sep 30, 2022
($16.64M)
Nov 14, 2023
Q3
2023
Jun 30, 2022
($11.55M)
Nov 14, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($16.95M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($16.80M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($16.40M)
May 6, 2025
Q3
2025
Sep 30, 2024
($15.22M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($13.36M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($16.30M)
May 6, 2025
Q3
2024
Sep 30, 2023
($43.88M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($15.19M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($14.96M)
May 9, 2024
Q3
2023
Sep 30, 2022
($14.75M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($21.77M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($11.76M)
May 9, 2023
Q3
2022
Sep 30, 2021
($11.42M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($9.00M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.2K)
May 16, 2022